The FDA recommends Wegovy for weight loss if you meet one of the following criteria: Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol Have a BMI of 30kg/m2 or greater Avoid semaglutide if you have: History of medullary thyroid cancer History of gallbladder disease History of pancreatitis Multiple endocrine neoplasia syndrome type 2 (MEN2) If youre considering semaglutide for weight loss, your first step should be consulting your primary care physician (PCP)
In addition to altering dosage and staying hydrated the following dieatary considerations may help: eating more slowly consuming smaller meals selecting more bland, low-fat foods (like crackers, toast and rice) avoiding greasy, fried foods eating foods that contain water (like soup or gelatin) not lying down after eating going outside for fresh air By implementing these strategies and maintaining open communication with healthcare providers, patients can effectively manage the side effects of Wegovy, improving their overall treatment experience and outcomes
Obesity has been associated with OSA through several mechanisms: (i) direct fat deposition within the upper airway or in its walls, which reduces the respiratory lumen
After screening the samples that Raufman prepared, they discovered exendin-4, a peptide molecule composed of 39 amino acids
Curr Hypertens Rep
